Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes

Clinical Microbiology and Infection

Volumn 16, Issue 7, 2010, Pages 948-954

  Ladhani, S ^a   Heath, P T ^b   Slack, M P E ^a   McIntyre, P B ^c   Diez Domingo, J ^d   Campos, J ^e   Dagan, R ^f   Ramsay, M E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d Centro Superior de Investigacion en Salud Publica CSISP   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Conjugate vaccine; Haemophilus influenzae b (Hib); Underlying diseases; Vaccine failure

Indexed keywords

ANTIBODY; HAEMOPHILUS INFLUENZAE ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; AUSTRALIA; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; EUROPE; FEMALE; HAEMOPHILUS INFECTION; HEALTH SURVEY; HUMAN; IMMUNOGLOBULIN DEFICIENCY; INFANT; ISRAEL; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREMATURITY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SINGLE DRUG DOSE; VACCINE FAILURE;

HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 77954647846     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02945.x     Document Type: Article

References (41)

1. Booy R, Hodgson S, Carpenter L. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet 1994, 344:362-366.
2. Eskola J, Takala A, Kayhty H. Secondary cases of invasive disease caused by spread of Haemophilus influenzae type b. J Infect 1987, 14:233-236.
3. Black SB, Shinefield HR, Fireman B, Hiatt R, Polen M, Vittinghoff E. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J 1991, 10:97-104.
4. Santosham M, Wolff M, Reid R. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991, 324:1767-1772.
5. Ramsay ME, McVernon J, Andrews NJ, Heath PT, Slack MP. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis 2003, 188:481-485.
6. Heath PT, Booy R, Azzopardi HJ. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA 2000, 284:2334-2340.
7. Heath PT, McVernon J. The UK Hib vaccine experience. Arch Dis Child 2002, 86:396-399.
8. Fogarty J, Moloney AC, Newell JB. The epidemiology of Haemophilus influenzae type b disease in the Republic of Ireland. Epidemiol Infect 1995, 114:451-463.
9. Herceg A. The decline of Haemophilus influenzae type b disease in Australia. Commun Dis Intell 1997, 21:173-176.
10. Hargreaves RM, Slack MP, Howard AJ, Anderson E, Ramsay ME. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ 1996, 312:160-161.
11. Garpenholt O, Silfverdal SA, Hugosson S. The impact of Haemophilus influenzae type b vaccination in Sweden. Scand J Infect Dis 1996, 28:165-169.
12. Heath PT, Booy R, Griffiths H. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis 2000, 31:973-980.
13. Holmes SJ, Lucas AH, Osterholm MT, Froeschle JE, Granoff DM. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group. JAMA 1991, 266:1960-1965.
14. Holmes SJ, Granoff DM. The biology of Haemophilus influenzae type b vaccination failure. J Infect Dis 1992, 165(suppl 1):S121-S128.
15. Breukels MA, Spanjaard L, Sanders LA, Rijkers GT. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants. Clin Infect Dis 2001, 32:1700-1705.
16. Phipps DC, West J, Eby R, Koster M, Madore DV, Quataert SA. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods 1990, 135:121-128.
17. Madore DV, Anderson P, Baxter BD. Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 1996, 3:84-88.
18. Lee YC, Kelly DF, Yu LM. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Clin Infect Dis 2008, 46:186-192.
19. Milford-Ward A. PRU handbook of clinical immunochemistry 1996, 5th edn, Sheffield, PRU Publications
20. Hugosson S, Silfverdal SA, Garpenholt O. Invasive Haemophilus influenzae disease: epidemiology and clinical spectrum before large-scale H. influenzae type b vaccination. Scand J Infect Dis 1995, 27:63-67.
21. Gervaix A, Suter S. Epidemiology of invasive Haemophilus influenzae type b infections in Geneva, Switzerland, 1976 to 1989. Pediatr Infect Dis J 1991, 10:370-374.
22. Takala AK, Eskola J, Peltola H, Makela PH. Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J 1989, 8:297-302.
23. Booy R, Hodgson SA, Slack MP, Anderson EC, Mayon-White RT, Moxon ER. Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91). Arch Dis Child 1993, 69:225-228.
24. McGregor AR, Bell JM, Abdool IM, Collignon PJ. Invasive Haemophilus influenzae infection in the Australian Capital Territory region. Med J Aust 1992, 156:569-572.
25. Eskola J, Kayhthy H. Ten years' experience with Haemophilus influenzae type (Hib) conjugate vaccines in Finland. Rev Med Microbiol 1996, 7:231-241.
26. Kristensen K. Carriage and antibiotic susceptibility of Haemophilus influenzae type b and non b in Danish day-care attendees. APMIS 1990, 98:50-52.
27. Hanna JN. The epidemiology of invasive Haemophilus influenzae infections in children under five years of age in the Northern Territory: a three-year study. Med J Aust 1990, 152:234-240.
28. Reinert P, Liwartowski A, Dabernat H, Guyot C, Boucher J, Carrere C. Epidemiology of Haemophilus influenzae type b disease in France. Vaccine 1993, 11(suppl 1):S38-S42.
29. van Alphen L, Spanjaard L, van der Ende A, Schuurman I, Dankert J. Effect of nationwide vaccination of 3-month-old infants in The Netherlands with conjugate Haemophilus influenzae type b vaccine: high efficacy and lack of herd immunity. J Pediatr 1997, 131:869-873.
30. McIntyre PB, Leeder SR, Irwig LM. Invasive Haemophilus influenzae type b disease in Sydney children 1985-1987: a population-based study. Med J Aust 1991, 154:832-837.
31. Ladhani S, Neely F, Heath PT. Recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease. J Infect 2009, 58:3-14.
32. Johnson PD, Hanlon M, Isaacs D, Gilbert GL. Differing antibody responses to Haemophilus influenzae type b after meningitis or epiglottitis. Epidemiol Infect 1996, 116:21-26.
33. Auckland C, Gray S, Borrow R. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J Infect Dis 2006, 194:1745-1752.
34. Cates KL, Krause PJ, Murphy TV, Stutman HR, Granoff DM. Second episodes of Haemophilus influenzae type b disease following rifampin prophylaxis of the index patients. Pediatr Infect Dis J 1987, 6:512-515.
35. Heath PT, Booy R, McVernon J. Hib vaccination in infants born prematurely. Arch Dis Child 2003, 88:206-210.
36. Omenaca F, Garcia-Sicilia J, Garcia-Corbeira P. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue. Pediatrics 2005, 116:1292-1298.
37. Costa-Carvalho BT, Martinez RM, Dias AT. Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Braz J Med Biol Res 2006, 39:1587-1592.
38. Avanzini MA, Soderstrom T, Wahl M, Plebani A, Burgio GR, Hanson LA. IgG subclass deficiency in patients with Down's syndrome and aberrant hepatitis B vaccine response. Scand J Immunol 1988, 28:465-470.
39. NHS Maternity Statistics, England: 1998-99 to 2000-01 2002, http://www.dh.gov.uk/en/Publicationsandstatistics/Statistics/StatisticalWorkAreas/Statisticalhealthcare/DH_4086519, Crown Copyright, Available at (last accessed 1 May 2009)
40. Ladhani S, Slack MP, Heys M, White J, Ramsay ME. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch Dis Child 2008, 93:665-669.
41. Fitzgerald M, Cotter S, O'Flanagan D. Invasive Haemophilus influenzae type b disease in Ireland, 2006/7. EPI-Insight 2007, 8:4.